Search results
New York Rangers captain Jacob Trouba may be the most interesting man in hockey, on and off the ice
Associated Press via AOL· 5 hours agoJacob Trouba is captain of the best team in the NHL this season, the New York Rangers, one of the...
EXPLAINER: What we know about AstraZeneca blood clot reports
AOL· 3 days agoGerman officials have decided to limit the use of AstraZeneca’s coronavirus vaccine in people under...
Pharma Stock Roundup: JNJ's Q1 Results, LLY, ABBV, RHHBY's Successful Study Data
Zacks via Yahoo Finance· 7 hours agoWatch this space for first-quarter earnings of Merck, Novartis, Sanofi, AstraZeneca and AbbVie...
Baroness Chakrabarti scolded by Lords leader after shouting at health minister
Press Association News via AOL· 3 days agoThe former Liberty director lost her cool after Lord Markham said he was proud of the UK’s record on...
DOJ Provides Further Guidance to Competitor Collaborations Related to COVID-19 Response
The National Law Review· 7 days agoIn response to the COVID-19 pandemic, the Antitrust Division of the Department of Justice (DOJ) committed to issuing expedited “Business Review Letters” ...
Omicron more likely to reinfect than Delta, no milder: Study
AOL· 3 days agoThe results of the study by Imperial College London were based on UK Health Security Agency and...
Saïd Dean On The Big Challenge Facing The World’s Elite Business Schools
Poets & Quants via Yahoo Finance· 3 days agoSoumitra Dutta, dean of the University of Oxford Saïd Business School If the world’s elite business...
Calls for major change as 'unacceptable' deaths of 460,000 Aussie animals exposed
Yahoo News Australia· 2 weeks ago“For example, when testing vaccines before human clinical trials, such as the pre-clinical trials of...
3 Pharma Stocks That Are Money-Printing Machines in 2024
InvestorPlace· 4 days agoThe future of the U.S. economy appears promising, with robust growth and strong corporate...
Small Business - Salisbury Post | Salisbury Post
The Salisbury Post· 1 day agoQuebec's INESSS recommends BEYFORTUS® for the prevention of RSV for all infants 8 months of age and younger(1) Canada NewsWire TORONTO, April 18, 2024 BEYFORTUS® (nirsevimab) is the first long-acting antibody approved in Canada for the prevention